Eikon Therapeutics
Biotechnology Research • Millbrae, California, United States
Eikon Therapeutics is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs. We are passionate about novel therapeutics and share the belief that a better understanding of fundamental human disease biology can lead to better medicines. We are driven to go beyond incremental improvements. Instead, our goal is to introduce new therapies into clinical practice that will improve and extend life. Our clinical programs in oncology leverage immune response modulation and synthetic lethality to improve cancer therapy, while our discovery efforts are focused on identifying novel targets through applicatio…
Reported headcount
414
Headcount reported in the resolved company record. It is independent of the number of profiles indexed by Super Carl.
Company record. Source date unavailable.
Observed active job postings
47
Active postings in the available job data. Postings may be duplicated or stale and are not a verified count of vacancies or hires.
Indexed job postings. Source date unavailable.
Reported annual revenue estimate
$5.6M
Annual revenue from the resolved company record; estimates may differ from filed accounts.
Company record. Source date unavailable. Estimate.
Reported total funding
$1.5B
Reported cumulative funding in the available company record; missing value does not mean no funding.
Company record. Source date unavailable.
Reported latest funding round
$381.2M
Reported amount of the latest funding round available in the company record.
Company record. Source date unavailable.
Calculated as of 2026-10-23. Source records may be older.